Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 158.


Elliot, Emillie, Neary, MG ORCID: 0000-0002-4960-2139, Else, Laura, Khoo, Saye ORCID: 0000-0002-2769-0967, Moyle, Graeme, Carr, Dan, Owen, Andrew ORCID: 0000-0002-9819-7651 and Boffito, Marta
(2018) ABCG2 rs2231142 and NR1I2 rs2472677 influence dolutegravir concentrations in plasma. In: CROI, Boston, MA, USA.


Griffiths, Gareth O, FitzGerald, Richard, Jaki, Thomas, Corkhill, Andrea, Reynolds, Helen ORCID: 0000-0001-7443-4520, Ewings, Sean, Condie, Susannah, Tilt, Emma, Johnson, Lucy, Radford, Mike
et al (show 27 more authors) (2021) AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. TRIALS, 22 (1). 487-.


Curley, Paul ORCID: 0000-0003-4596-2708, Liptrott, Neill J ORCID: 0000-0002-5980-8966 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) Advances in nanomedicine drug delivery applications for HIV therapy. FUTURE SCIENCE OA, 4 (1). FSO230-.


Hobson, James J ORCID: 0000-0003-2551-1774, Curley, Paul ORCID: 0000-0003-4596-2708, Savage, Alison C ORCID: 0000-0002-5312-9946, Al-khouja, Amer, Siccardi, Marco ORCID: 0000-0002-3539-7867, Flexner, Charles, Meyers, Caren Freel, Owen, Andrew ORCID: 0000-0002-9819-7651 and Rannard, Steve P ORCID: 0000-0002-6946-1097
(2019) Anhydrous nanoprecipitation for the preparation of nanodispersions of tenofovir disoproxil fumarate in oils as candidate long-acting injectable depot formulations. NANOSCALE ADVANCES, 1 (11). pp. 4301-4307.


David, Christopher AW ORCID: 0000-0001-8504-2354, del Castillo Busto, M Estela, Cuello-Nunez, Susana, Goenaga-Infante, Heidi, Barrow, Michael, Fernig, David G ORCID: 0000-0003-4875-4293, Murray, Patricia, Rosseinsky, Matthew J ORCID: 0000-0002-1910-2483, Owen, Andrew ORCID: 0000-0002-9819-7651 and Liptrott, Neill J ORCID: 0000-0002-5980-8966
(2021) Assessment of changes in autophagic vesicles in human immune cell lines exposed to nano particles. CELL AND BIOSCIENCE, 11 (1). 133-.


Chan, CY
(2018) Assessment of degradation rate constants for quantitative predictions of drug-drug interactions arising from CYP450 drug metabolising enzymes. PhD thesis, University of Liverpool.


Liptrott, Neill J ORCID: 0000-0002-5980-8966, Giardiello, Marco ORCID: 0000-0003-0560-4711, McDonald, Tom O ORCID: 0000-0002-9273-9173, Rannard, Steve P ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems. JOURNAL OF NANOBIOTECHNOLOGY, 16 (1). 22-.


Neary, MG ORCID: 0000-0002-4960-2139
(2018) Assessment of the inter-individual variation observed between patients receiving HIV antiretroviral therapy. PhD thesis, University of Liverpool.


Nwogu, Jacinta N, Gandhi, Monica, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Taiwo, Babafemi, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Berzins, Baiba, Okochi, Hideaki, Tallerico, Regina, Robertson, Kevin
et al (show 1 more authors) (2021) Associations between efavirenz concentrations, pharmacogenetics, and neurocognitive performance in people living with HIV in Nigeria. AIDS (London, England), 35 (12). pp. 1919-1927.


Akinloye, Abdulafeez, Oyedeji, Timothy, Eniayewu, Oluwasegun, Adeagbo, Babatunde, Bolaji, Oluseye, Rannard, Steve, Owen, Andrew and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2023) Atazanavir/ritonavir increased tizoxanide exposure from oral nitazoxanide through pharmacokinetic interaction in healthy volunteers. [Preprint]


Hobson, James ORCID: 0000-0003-2551-1774, Edwards, Stephanie ORCID: 0000-0002-4959-0158, Slater, Rebecca, Martin, Phillip, Owen, Andrew ORCID: 0000-0002-9819-7651 and Rannard, SP ORCID: 0000-0002-6946-1097
(2018) Branched copolymer-stabilised nanoemulsions as new candidate oral drug delivery systems. RSC Advances, 8 (23). pp. 12984-12991.


Olagunju, Adeniyi, Bolaji, Oluseye, Amara, Alieu, Waitt, Catriona, Else, Laura, Adejuyigbe, Ebunoluwa, Siccardi, Marco, Back, David, Khoo, Saye and Owen, Andrew
(2015) Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically-defined subgroups of mother-infant pairs: an observational study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.


Neary, MG ORCID: 0000-0002-4960-2139, Chappell, Catherine, Scarsi, Kimberly, Nakalema, Shadia, Matovu, Joshua, Achilles, Sharon, Chen, Beatrice, Siccardi, Marco ORCID: 0000-0002-3539-7867, Owen, Andrew ORCID: 0000-0002-9819-7651 and Lamorde, Mohammed
(2018) CYP2B6 variants alter etonogestrel pharmacokinetics when combined with efavirenz. In: CROI, 2018-3-5 - 2018-3-8, Boston, MA, USA.


Winston, Alan, Amin, Janaki, Clarke, Amanda, Else, Laura, Amara, Alieu ORCID: 0000-0002-1137-2948, Owen, Andrew ORCID: 0000-0002-9819-7651, Barber, Tristan, Jessen, Heiko, Avinghsanon, Anchalee, Chetchotisakd, Ploenchan
et al (show 4 more authors) (2015) Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial. CLINICAL INFECTIOUS DISEASES, 60 (7). pp. 1026-1032.


Gallardo-Toledo, Eduardo ORCID: 0009-0000-8534-9030, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne ORCID: 0000-0001-8482-5736, Herriott, Joanne, Kijak, Edyta, Bramwell, Chloe ORCID: 0000-0001-8274-457X, Curley, Paul ORCID: 0000-0003-4596-2708, Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712
et al (show 6 more authors) (2023) Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters. Viruses, 15 (11). 2161-.


Balta, Victoria A ORCID: 0000-0003-0685-6697, Stiffler, Deborah, Sayeed, Abeer, Tripathi, Abhai K ORCID: 0000-0001-9848-0142, Elahi, Rubayet, Mlambo, Godfree, Bakshi, Rahul P, Dziedzic, Amanda G, Jedlicka, Anne E ORCID: 0000-0003-3826-2973, Nenortas, Elizabeth
et al (show 8 more authors) (2023) Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito. Nature communications, 14 (1). 6415-.


Rannard, SP ORCID: 0000-0002-6946-1097, Owen, Andrew ORCID: 0000-0002-9819-7651 and Hern, Faye
(2018) Co-initiated hyperbranched-polydendron building blocks for the direct nanoprecipitation of dendron-directed patchy particles with heterogeneous surface functionality. Polymer Chemistry, 9 (14). pp. 1767-1771.


Nwogu, Jacinta N, Ngene, Samuel O, Babalola, Chinedum P, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye H, Kotila, Olayinka A, Berzins, Baiba, Okochi, Hideaki, Tallerico, Regina
et al (show 2 more authors) (2022) Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria. AIDS RESEARCH AND THERAPY, 19 (1). 35-.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Amin, Janaki, Else, Laura, Boffito, Marta, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, Catherine, Clarke, Amanda
et al (show 6 more authors) (2016) Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naive HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. CLINICAL PHARMACOKINETICS, 55 (7). pp. 861-873.


Elbaz, Nancy M, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve ORCID: 0000-0002-6946-1097 and McDonald, Tom O ORCID: 0000-0002-9273-9173
(2020) Controlled synthesis of calcium carbonate nanoparticles and stimuli-responsive multi-layered nanocapsules for oral drug delivery. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 574. 118866-.


Arshad, Usman ORCID: 0000-0003-1586-1885, Sutton, Paul A, Ashford, Marianne B, Treacher, Kevin E, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Rannard, Steve P ORCID: 0000-0002-6946-1097, Goldring, Christopher E and Owen, Andrew ORCID: 0000-0002-9819-7651
(2020) Critical considerations for targeting colorectal liver metastases with nanotechnology. WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 12 (2). e1588-.


Chan, Christina YS, Roberts, Owain, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Siccardi, Marco ORCID: 0000-0002-3539-7867, Almond, Lisa and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approach. DRUG METABOLISM AND PHARMACOKINETICS, 33 (4). pp. 179-187.


Rogers, Hannah E, Chambon, Pierre, Flynn, Sean ORCID: 0000-0001-6028-3389, Hern, Faye Y, Owen, Andrew ORCID: 0000-0002-9819-7651 and Rannard, Steve P ORCID: 0000-0002-6946-1097
(2020) Designing single trigger/dual-response release and degradation into amine-functional hyperbranched-polydendron nanoprecipitates. NANOSCALE ADVANCES, 2 (11). pp. 5468-5477.


Williamson, Beth
Determinants of transcriptional regulation of transport and oxidative processes in human model systems. Doctor of Philosophy thesis, University of Liverpool.


Tidbury, Louise
(2018) Development and biological assessment of prednisolone solid drug nanoparticles. PhD thesis, University of Liverpool.


Curley, Paul ORCID: 0000-0003-4596-2708, Siccardi, Marco ORCID: 0000-0002-3539-7867, Moss, Darren M and Owen, Andrew ORCID: 0000-0002-9819-7651
(2016) Development and validation of an LC-MS/MS assay for the quantification of efavirenz in different biological matrices. BIOANALYSIS, 8 (20). pp. 2125-2134.


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Bolaji, Oluseye O, Amara, Alieu ORCID: 0000-0002-1137-2948, Waitt, Catriona ORCID: 0000-0003-0134-5855, Else, Laura, Soyinka, Julius, Adeagbo, Babatunde, Adejuyigbe, Ebunoluwa, Siccardi, Marco ORCID: 0000-0002-3539-7867, Back, David
et al (show 2 more authors) (2015) Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 70 (2). pp. 555-561.


Abdullahi, Sa'ad T, Soyinka, Julius O, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Bolarinwa, Rahman A, Olarewaju, Olusola J, Bakare-Odunola, Moji T, Winterberg, Markus, Tarning, Joel, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2020) Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by <i>CYP2B6</i> c.516G&gt;T Genotypes. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 64 (3). e00947-e00919.


Hern, Faye, Tatham, Lee ORCID: 0000-0001-9448-8876, Owen, Andrew ORCID: 0000-0002-9819-7651 and Rannard, Steve ORCID: 0000-0002-6946-1097
(2018) Direct synthesis of nanoparticles with spatial heterogeneity for tailored cellular interactions. PhD thesis, University of Liverpool.


Elliot, Emilie, Amara, Alieu ORCID: 0000-0002-1137-2948, Jackson, Akil ORCID: 0000-0002-4574-544X, Moyle, Graeme, Else, Laura, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Owen, Andrew ORCID: 0000-0002-9819-7651 and Boffito, Marta
(2016) Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71 (4). pp. 1031-1036.


Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Pertinez, Henry, Arshad, Usman ORCID: 0000-0003-1586-1885, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 13 more authors) (2021) Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (4). pp. 2078-2088.


Rajoli, Rajith Kr ORCID: 0000-0002-6015-5712, Pertinez, Henry, Arshad, Usman ORCID: 0000-0003-1586-1885, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 13 more authors) (2020) Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. medRxiv : the preprint server for health sciences.


Brain, Danielle ORCID: 0000-0002-1671-8477, Plant-Hately, Alex ORCID: 0000-0003-2425-1990, Heaton, Bethany ORCID: 0000-0002-1495-1945, Arshad, Usman ORCID: 0000-0003-1586-1885, David, Christopher ORCID: 0000-0001-8504-2354, Hedrich, Christian ORCID: 0000-0002-1295-6179, Owen, Andrew ORCID: 0000-0002-9819-7651 and Liptrott, Neill J ORCID: 0000-0002-5980-8966
(2021) Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. ADVANCED DRUG DELIVERY REVIEWS, 178. 113848-.


Sirijatuphat, Rujipas, Manosuthi, Weerawat, Niyomnaitham, Suvimol, Owen, Andrew ORCID: 0000-0002-9819-7651, Copeland, Katherine Kradangna, Charoenpong, Lantharita, Rattanasompattikul, Manoch, Mahasirimongkol, Surakameth, Wichukchinda, Nuanjun and Chokephaibulkit, Kulkanya
(2022) Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study. EMERGING MICROBES & INFECTIONS, 11 (1). pp. 2197-2206.


Curley, Paul ORCID: 0000-0003-4596-2708, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Moss, Darren M, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Letendre, Scott, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2017) Efavirenz Is Predicted To Accumulate in Brain Tissue: an <i>In Silico</i>, <i>In Vitro</i>, and <i>In Vivo</i> Investigation. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (1). e01841-e01816.


Adegbola, Adebanjo, Abutaima, Rana, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Ijarotimi, Omotade, Siccardi, Marco ORCID: 0000-0002-3539-7867, Owen, Andrew ORCID: 0000-0002-9819-7651, Soyinka, Julius and Bolaji, Oluseye
(2018) Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria Coinfection. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62 (10). e01252-e01218.


Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Walker, A Sarah, Owen, Andrew ORCID: 0000-0002-9819-7651, Gibb, Diana M, Burger, David
et al (show 2 more authors) (2017) Effect of diurnal variation, <i>CYP2B6</i> genotype and age on the pharmacokinetics of nevirapine in African children. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72 (1). pp. 190-199.


Cirrincione, Lauren R, Nakalema, Shadia, Chappell, Catherine A, Byakika-Kibwika, Pauline, Kyohairwe, Isabella, Winchester, Lee, Mackline, Hope, Pham, Michelle M, Cohn, Susan E, Siccardi, Marco ORCID: 0000-0002-3539-7867
et al (show 4 more authors) (2023) Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study. Contraception, 122. p. 109975.


Neary, Megan ORCID: 0000-0002-4960-2139, Chappell, Catherine A, Scarsi, Kimberly K, Nakalema, Shadia, Matovu, Joshua, Achilles, Sharon L, Chen, Beatrice A, Siccardi, Marco ORCID: 0000-0002-3539-7867, Owen, Andrew ORCID: 0000-0002-9819-7651 and Lamorde, Mohammed
(2019) Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (10). pp. 3003-3010.


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez
et al (show 6 more authors) (2021) Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials, 22 (1). 3-.


Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Gallardo-Toledo, Eduardo, Herriott, Joanne, Kijak, Edyta, Bramwell, Chloe, Cox, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Box, Helen, Curley, Paul ORCID: 0000-0003-4596-2708
et al (show 11 more authors) (2023) Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters. VIRUSES-BASEL, 15 (8). 1744-.


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Schipani, Alessandro, Bolaji, Oluseye, Khoo, Saye ORCID: 0000-0002-2769-0967 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73 (1). pp. 165-172.


Morris, Sam, Long, Mark, Savage, Alison ORCID: 0000-0002-5312-9946, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve ORCID: 0000-0002-6946-1097 and Cauldbeck, Helen ORCID: 0000-0002-2853-8457
(2023) Ex vivo transdermal delivery of 3H-labelled atovaquone solid drug nanoparticles: a comparison of topical, intradermal injection and microneedle assisted administration. Nanoscale Advances, 5 (23). pp. 6400-6404.


Bunglawala, Fazila
(2022) Exploring the Applications of PBPK Modelling to Optimise HIV-1 Treatment. PhD thesis, University of Liverpool.


Obradovic, Bozana, Roberts, Owain, Owen, Andrew ORCID: 0000-0002-9819-7651, Milosevic, Ivana, Milic, Natasa, Ranin, Jovan and Dragovic, Gordana
(2023) Expression of CYP2B6 Enzyme in Human Liver Tissue of HIV and HCV Patients. MEDICINA-LITHUANIA, 59 (7). 1207-.


Brevini, Teresa, Maes, Mailis, Webb, Gwilym J, John, Binu V, Fuchs, Claudia D, Buescher, Gustav, Wang, Lu, Griffiths, Chelsea, Brown, Marnie L, Scott, William EIII
et al (show 69 more authors) (2023) FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. NATURE, 615 (7950). 134-+.


Smith, Tania, Hoyo-Vadillo, Carlos, Adom, Akosua Agyeman, Favari-Perozzi, Liliana, Gastine, Silke, Dehbi, Hakim-Moulay, Villegas-Lara, Beatriz, Mateos, Eduardo, Gonzalez, Yessica Sara Perez, Navarro-Gualito, Maria D
et al (show 10 more authors) (2022) Favipiravir and/or nitazoxanide: a randomized, double-blind, 2x2 design, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE). TRIALS, 23 (1). 583-.


Sloan, Derek J, McCallum, Andrew D, Schipani, Alessandro, Egan, Deirdre, Mwandumba, Henry C, Ward, Steve A, Waterhouse, David, Banda, Gertrude, Allain, Theresa J, Owen, Andrew ORCID: 0000-0002-9819-7651
et al (show 2 more authors) (2017) Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (7). e00210-e00217.


Elliot, Emilie R, Neary, Megan ORCID: 0000-0002-4960-2139, Else, Laura, Khoo, Saye ORCID: 0000-0002-2769-0967, Moyle, Graeme, Carr, Daniel F, Wang, Xinzhu, Mcclure, Myra, Boffito, Marta and Owen, Andrew ORCID: 0000-0002-9819-7651
(2020) Genetic influence of <i>ABCG2, UGT1A1</i> and <i>NR1I2</i> on dolutegravir plasma pharmacokinetics. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (5). pp. 1259-1266.


Neary, Megan ORCID: 0000-0002-4960-2139, Owen, Andrew ORCID: 0000-0002-9819-7651 and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2022) A Holistic Review of the Preclinical Landscape for Long-Acting Anti-infective Drugs Using HIV as a Paradigm. Clinical Infectious Diseases, 75 (Supple). S490-S497.


Gurjar, R
(2019) INVESTIGATION OF MOLECULAR MECHANISMS REGULATING DRUG-DRUG INTERACTIONS IN ANTIRETROVIRAL THERAPY. PhD thesis, University of Liverpool.


Chandiwana, Nomathemba C, Serenata, Celicia M, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve ORCID: 0000-0002-6946-1097, Casas, Carmen Perez, Scott, Cherise, Hill, Andrew, Clayden, Polly and Flexner, Charles
(2021) Impact of long-acting therapies on the global HIV epidemic. AIDS, 35 (Suppl ). S137-S143.


Savage, Alison C ORCID: 0000-0002-5312-9946, Tatham, Lee M ORCID: 0000-0001-9448-8876, Siccardi, Marco ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Clark, Andrew, Rannard, Steve P ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2019) Improving maraviroc oral bioavailability by formation of solid drug nanoparticles. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 138. pp. 30-36.


David, Christopher AW ORCID: 0000-0001-8504-2354, Barrow, Michael, Murray, Patricia, Rosseinsky, Matthew J ORCID: 0000-0002-1910-2483, Owen, Andrew ORCID: 0000-0002-9819-7651 and Liptrott, Neill J ORCID: 0000-0002-5980-8966
(2020) In Vitro Determination of the Immunogenic Impact of Nanomaterials on Primary Peripheral Blood Mononuclear Cells. International Journal of Molecular Sciences, 21 (16). p. 5610.


Roberts, Owain, Kinvig, Hannah ORCID: 0000-0002-0061-1683, Owen, Andrew ORCID: 0000-0002-9819-7651, Lamorde, Mohammed, Siccardi, Marco ORCID: 0000-0002-3539-7867 and Scarsi, Kimberly K
(2021) In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel. HIV MEDICINE, 22 (10). pp. 898-906.


Curley, Paul ORCID: 0000-0003-4596-2708, Giardiello, Marco ORCID: 0000-0003-0560-4711, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Dickens, David ORCID: 0000-0001-8295-0752, Moss, Darren M, Hobson, James J ORCID: 0000-0003-2551-1774, Savage, Alison C, McDonald, Tom O, Siccardi, Marco, Rannard, Steve
et al (show 1 more authors) (2017) In vitro characterisation of solid drug nanoparticle compositions of efavirenz in a brain endothelium cell line. Journal of Interdisciplinary Nanomedicine, 2 (3). pp. 157-169.


Abutaima, Rana
(2018) In vitro, in vivo and in silico approaches to investigate pharmacokinetics and pharmacogenetics in HIV therapy. PhD thesis, University of Liverpool.


Chan, Christina, Martin, Philip, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Siccardi, Marco ORCID: 0000-0002-3539-7867, Almond, Lisa and Owen, Andrew ORCID: 0000-0002-9819-7651
(2017) Incompatibility of chemical protein synthesis inhibitors with accurate measurement of extended protein degradation rates. PHARMACOLOGY RESEARCH & PERSPECTIVES, 5 (5). e00359-e00359.


Gurjar, Rohan, Dickinson, Laura ORCID: 0000-0001-5557-9396, Carr, Daniel, Stohr, Wolfgang, Bonora, Stefano, Owen, Andrew ORCID: 0000-0002-9819-7651, D'Avolio, Antonio, Cursley, Adam, De Castro, Nathalie, Fatkenheuer, Gerd
et al (show 6 more authors) (2022) Influence of <i>UGT1A1</i> and <i>SLC22A6</i> polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study. PHARMACOGENOMICS JOURNAL, 23 (1). pp. 14-20.


Kinvig, Hannah ORCID: 0000-0002-0061-1683
(2021) Integrated Experimental and Computational Approaches for the Prediction of Drug-Drug Interactions. PhD thesis, University of Liverpool.


Roberts, Owain, Khoo, Saye ORCID: 0000-0002-2769-0967, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2017) Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat <i>In Vitro</i>. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (5). e01776-e01716.


Donnellan, Samantha, Stone, Vicki, Johnston, Helinor, Giardiello, Marco ORCID: 0000-0003-0560-4711, Owen, Andrew, Rannard, Steve, Aljayyoussi, Ghaith, Swift, Benjamin, Tran, Lang, Watkins, Craig
et al (show 1 more authors) (2017) Intracellular delivery of nano-formulated antituberculosis drugs enhances bactericidal activity. Journal of Interdisciplinary Nanomedicine, 2 (3). pp. 146-156.


Gini, J
(2018) Investigating the Effectiveness of Antiretroviral Therapy in sub-Saharan Africa. Doctor of Philosophy thesis, University of Liverpool.


Brain, Danielle ORCID: 0000-0002-1671-8477
(2023) Investigating the impact of, novel, therapeutic delivery systems on immunological responses - determination of short, and long-term, exposure effects. PhD thesis, University of Liverpool.


Box, Helen J, Sharp, Joanne, Pennington, Shaun H, Kijak, Edyta, Tatham, Lee ORCID: 0000-0001-9448-8876, Caygill, Claire H, Lopeman, Rose C, Jeffreys, Laura N, Herriott, Joanne, Neary, Megan
et al (show 15 more authors) (2023) Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters. The Journal of antimicrobial chemotherapy, 79 (1). dkad362-dkad362.


Liptrott, Neill J ORCID: 0000-0002-5980-8966, Giardiello, Marco ORCID: 0000-0003-0560-4711, McDonald, Tom O ORCID: 0000-0002-9273-9173, Rannard, Steven P ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2017) Lack of interaction of lopinavir solid drug nanoparticles with cells of the immune system. NANOMEDICINE, 12 (17). pp. 2043-2054.


Elbaz, Nancy M, Tatham, Lee M ORCID: 0000-0001-9448-8876, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve ORCID: 0000-0002-6946-1097 and McDonald, Tom O ORCID: 0000-0002-9273-9173
(2023) Layer by layer self-assembly for coating a nanosuspension to modify drug release and stability for oral delivery. Food Hydrocolloids, 144. p. 108908.


Shakil, Anika, Hern, Faye Y, Liu, Chung, Temburnikar, Kartik, Chambon, Pierre, Liptrott, Neill ORCID: 0000-0002-5980-8966, McDonald, Tom O ORCID: 0000-0002-9273-9173, Neary, Megan ORCID: 0000-0002-4960-2139, Owen, Andrew ORCID: 0000-0002-9819-7651, Freel Meyers, Caren
et al (show 1 more authors) (2022) Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants. JOURNAL OF MATERIALS CHEMISTRY B, 10 (23). pp. 4395-4404.


Tatham, Lee M ORCID: 0000-0001-9448-8876, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Rannard, Steve P ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2019) Long-Acting Injectable Statins-Is It Time for a Paradigm Shift? MOLECULES, 24 (15). E2685-.


Bakshi, Rahul P, Tatham, Lee M ORCID: 0000-0001-9448-8876, Savage, Alison C ORCID: 0000-0002-5312-9946, Tripathi, Abhai K, Mlambo, Godfree, Ippolito, Matthew M, Nenortas, Elizabeth, Rannard, SP ORCID: 0000-0002-6946-1097, Owen, Andrew ORCID: 0000-0002-9819-7651 and Shapiro, Theresa A
(2018) Long-acting injectable atovaquone nanomedicines for malaria prophylaxis. Nature Communications, 9 (1). 315-.


Kaboggoza, Julian P ORCID: 0000-0001-9510-0474, Wang, Xinxhu, Neary, Megan ORCID: 0000-0002-4960-2139, Ayuso, Pedro, Sekaggya-Wiltshire, Christine, Nakalema, Shadia, Owen, Andrew ORCID: 0000-0002-9819-7651, McClure, Myra, Lamorde, Mohammed and Boffito, Marta
(2019) A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients. OPEN FORUM INFECTIOUS DISEASES, 6 (2). ofz035-.


Ayuso, Pedro, Neary, Megan ORCID: 0000-0002-4960-2139, Chiong, Justin ORCID: 0000-0001-8063-6399 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2019) Meta-analysis of the effect of <i>CYP2B6, CYP2A6, UGT2B7</i> and <i>CAR</i> polymorphisms on efavirenz plasma concentrations. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (11). pp. 3281-3290.


Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Flexner, Charles, Chiong, Justin ORCID: 0000-0001-8063-6399, Owen, Andrew ORCID: 0000-0002-9819-7651, Donnelly, Ryan F, Larraneta, Eneko and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2019) Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 144. pp. 101-109.


David, Christopher ORCID: 0000-0001-8504-2354, Ahmed, Faraaz, Owen, Andrew ORCID: 0000-0002-9819-7651 and Liptrott, Neill ORCID: 0000-0002-5980-8966
(2017) Modulation of inflammasome activation through manipulation of autophagic processes in primary human immune cells. Journal of Interdisciplinary Nanomedicine.


Keshavjee, Salmaan, Amanullah, Farhana, Cattamanchi, Adithya, Chaisson, Richard, Dobos, Karen M, Fox, Gregory J, Gendelman, Howard E, Gordon, Richard, Hesseling, Anneke, Hoi, Le Van
et al (show 22 more authors) (2018) Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. American journal of respiratory and critical care medicine, 199 (5). pp. 564-571.


Gaynor, Katherine UU, Vaysburd, Marina, Harman, Maximilian AJ, Albecka, Anna, Jeffrey, Phillip, Beswick, Paul, Papa, Guido, Chen, Liuhong, Mallery, Donna, McGuinness, Brian
et al (show 22 more authors) (2023) Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2. NATURE COMMUNICATIONS, 14 (1). 3583-.


Mthiyane, Thuli, Millard, James ORCID: 0000-0001-6427-552X, Adamson, John, Balakrishna, Yusentha, Connolly, Cathy, Owen, Andrew ORCID: 0000-0002-9819-7651, Rustomjee, Roxana, Dheda, Keertan, McIlleron, Helen and Pym, Alexander S
(2020) N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-lsoniazid Pharmacokinetics during Antituberculosis Treatment. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 64 (4).


Mthiyane, Thuli, Millard, James ORCID: 0000-0001-6427-552X, Adamson, John, Balakrishna, Yusentha, Connolly, Cathy, Owen, Andrew ORCID: 0000-0002-9819-7651, Rustomjee, Roxana, Dheda, Keertan, McIlleron, Helen and Pym, Alexander S
(2020) N-acetyltransferase 2 genotypes amongst Zulu Speaking South Africans and isoniazid/N-acetyl-isoniazid pharmacokinetics during anti-tuberculosis treatment. Antimicrobial agents and chemotherapy, 64 (4). e02376-e02319.


Arshad, Usman ORCID: 0000-0003-1586-1885
(2021) Nanoparticle Interventions for Colorectal Cancer: Delivery of Polymer Encapsulated SN-38. PhD thesis, University of Liverpool.


Assmus, Frauke, Driouich, Jean-Selim, Abdelnabi, Rana, Vangeel, Laura, Touret, Franck, Adehin, Ayorinde, Chotsiri, Palang, Cochin, Maxime, Foo, Caroline S, Jochmans, Dirk
et al (show 21 more authors) (2022) Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19. MICROORGANISMS, 10 (8). 1639-.


Seehusen, Frauke, Clark, Jordan J, Sharma, Parul, Bentley, Eleanor G, Kirby, Adam, Subramaniam, Krishanthi, Wunderlin-Giuliani, Sabina, Hughes, Grant L, Patterson, Edward I, Michael, Benedict D ORCID: 0000-0002-8693-8926
et al (show 4 more authors) (2022) Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse. VIRUSES-BASEL, 14 (5). 1020-.


Seehusen, Frauke, Clark, Jordan ORCID: 0000-0003-1790-7883, Sharma, Parul, Bentley, Eleanor, Kirby, Adam, Subramaniam, Krishanthi ORCID: 0000-0002-7567-7185, Subramaniam, Krishanthi ORCID: 0000-0002-1734-9351, Giuliani, Sabina Wunderlin, Hughes, Grant, Patterson, Edward
et al (show 5 more authors) (2021) Neuroinvasion and neurotropism by SARS-CoV-2 variants in the K18-hACE2 mouse. [Preprint]


Walker, Lauren E ORCID: 0000-0002-3827-4387, FitzGerald, Richard, Saunders, Geoffrey, Lyon, Rebecca, Fisher, Michael, Martin, Karen, Eberhart, Izabela, Woods, Christie, Ewings, Sean, Hale, Colin
et al (show 23 more authors) (2022) An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2. CLINICAL PHARMACOLOGY & THERAPEUTICS, 111 (3). pp. 585-594.


Khoo, Saye H ORCID: 0000-0002-2769-0967, Fitzgerald, Richard, Fletcher, Thomas, Ewings, Sean, Jaki, Thomas, Lyon, Rebecca, Downs, Nichola, Walker, Lauren ORCID: 0000-0002-3827-4387, Tansley-Hancock, Olana, Greenhalf, William
et al (show 28 more authors) (2021) Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (12). pp. 3286-3295.


Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Valentijn, Anthony, Hobson, James ORCID: 0000-0003-2551-1774, Unsworth, Catherine
et al (show 6 more authors) (2021) Optimisation and validation of a sensitive bioanalytical method for niclosamide. [Preprint]


Elkateb, Heba, Tatham, Lee M ORCID: 0000-0001-9448-8876, Cauldbeck, Helen ORCID: 0000-0002-2853-8457, Niezabitowska, Edyta, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve ORCID: 0000-0002-6946-1097 and McDonald, Tom ORCID: 0000-0002-9273-9173
(2020) Optimization of the Synthetic Parameters of Lipid Polymer Hybrid Nanoparticles Dual Loaded with Darunavir and Ritonavir for the Treatment of HIV. International Journal of Pharmaceutics, 588. p. 119794.


Elliot, Emilie
(2020) THE PHARMACOKINETICS, PHARMACODYNAMICS AND PHARMACOGENETICS OF DOLUTEGRAVIR AND COBICISTAT IN THE TREATMENT OF HIV. PhD thesis, University of Liverpool.


Abdullahi, Sa'ad T, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Soyinka, Julius O, Bolarinwa, Rahman A, Olarewaju, Olusola J, Bakare-Odunola, Moji T, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2019) Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction? British journal of clinical pharmacology, 85 (3). pp. 540-550.


Dickinson, Laura, Amin, J, Else, Laura, Boffito, M, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, C, Clarke, A
et al (show 6 more authors) (2015) Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study. Clinical pharmacology and therapeutics, 98 (4). pp. 406-416.


Pertinez, Henry, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Khoo, Saye H ORCID: 0000-0002-2769-0967 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2021) Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-2. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (8). pp. 2121-2128.


Elliot, Emilie R, Cerrone, Maddalena, Challenger, Elizabeth ORCID: 0000-0002-8978-6067, Else, Laura, Amara, Alieu ORCID: 0000-0002-1137-2948, Bisdomini, Elisa, Khoo, Saye ORCID: 0000-0002-2769-0967, Owen, Andrew ORCID: 0000-0002-9819-7651 and Boffito, Marta
(2019) Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers (vol 74, pg 149, 2019). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (5). p. 1466.


Elliot, Emilie R, Cerrone, Maddalena, Else, Laura, Amara, Alieu ORCID: 0000-0002-1137-2948, Bisdomini, Elisa, Khoo, Saye ORCID: 0000-0002-2769-0967, Owen, Andrew ORCID: 0000-0002-9819-7651 and Boffito, Marta
(2019) Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers. The Journal of antimicrobial chemotherapy, 74 (1). pp. 149-156.


Kinvig, Hannah, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Pertinez, Henry, Vora, Lalitkumar K, Volpe-Zanutto, Fabiana, Donnelly, Ryan F, Rannard, Steve ORCID: 0000-0002-6946-1097, Flexner, Charles, Siccardi, Marco ORCID: 0000-0002-3539-7867 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2023) Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans. Pharmaceutics, 15 (12). p. 2709.


Roberts, Owain, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Back, David J, Owen, Andrew ORCID: 0000-0002-9819-7651, Darin, Kristin M, Fletcher, Courtney V, Lamorde, Mohammed, Scarsi, Kimberly K and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2018) Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug–drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART. Journal of Antimicrobial Chemotherapy, 73 (4). pp. 1004-1012.


Olagunju, A ORCID: 0000-0002-6588-5749, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Atoyebi, Shakir Adeyinka, Khoo, Saye ORCID: 0000-0002-2769-0967, Owen, Andrew and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2018) Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding. AAS Open Research, 1 (16).


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Rajoli, Rajith ORCID: 0000-0002-6015-5712, Atoyebi, Shakir ORCID: 0000-0002-1393-3753, Khoo, Saye, Owen, Andrew and Siccardi, Marco
(2018) Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding. AAS Open Research, 1. p. 16.


Waitt, Catriona ORCID: 0000-0003-0134-5855, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Nakalema, Shadia, Kyohaire, Isabella, Owen, Andrew ORCID: 0000-0002-9819-7651, Lamorde, Mohammed and Khoo, Saye ORCID: 0000-0002-2769-0967
(2018) Plasma and Breast Milk Pharmacokinetics of Emtricitabine, Tenofovir and Lamivudine Using Dried Blood and Breast Milk Spots in Nursing African Mother-Infant Pairs. Journal of Antimicrobial Chemotherapy, 73 (4). pp. 1013-1019.


Liu, Chung, Hern, Faye Y, Shakil, Anika, Temburnikar, Kartik, Chambon, Pierre, Liptrott, Neill ORCID: 0000-0002-5980-8966, McDonald, Tom O ORCID: 0000-0002-9273-9173, Neary, Megan, Flexner, Charles, Owen, Andrew ORCID: 0000-0002-9819-7651
et al (show 2 more authors) (2023) Polymer-prodrug conjugates as candidates for degradable, long-acting implants, releasing the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine. Journal of materials chemistry. B, 11 (48). pp. 11532-11543.


Francis, Jose, Zvada, Simbarashe P, Denti, Paolo, Hatherill, Mark, Charalambous, Salome, Mungofa, Stanley, Dawson, Rodney, Dorman, Susan, Gupte, Nikhil, Wiesner, Lubbe
et al (show 6 more authors) (2019) A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (4). e01964-e01918.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Gurjar, Rohan, Stoehr, Wolfgang, Bonora, Stefano, Owen, Andrew ORCID: 0000-0002-9819-7651, D'Avolio, Antonio, Cursley, Adam, Molina, Jean-Michel, Faeetkenheuer, Gerd, Vandekerckhove, Linos
et al (show 5 more authors) (2020) Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (3). pp. 628-639.


Ammerman, Nicole C, Nuermberger, Eric L, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve P ORCID: 0000-0002-6946-1097, Meyers, Caren Freel and Swindells, Susan
(2022) Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment. CLINICAL INFECTIOUS DISEASES, 75 (Suppl ). S510-S516.


Curley, Paul, Hobson, James J ORCID: 0000-0003-2551-1774, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Makarov, Edward, Al-Khouja, Amer, Tatham, Lee ORCID: 0000-0001-9448-8876, David, Christopher AW ORCID: 0000-0001-8504-2354, Box, Helen, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne
et al (show 7 more authors) (2023) Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations. Pharmaceutics, 15 (7). p. 1835.


Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Chiong, Justin ORCID: 0000-0001-8063-6399, Back, David, Flexner, Charles, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2019) Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. JOURNAL OF INFECTIOUS DISEASES, 219 (11). pp. 1735-1742.


Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Demkovich, Zach R, Flexner, Charles, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2020) Predicting pharmacokinetics of a tenofovir alafenamide subcutaneous implant using PBPK modelling. Antimicrobial Agents and Chemotherapy, 64 (8). e00155-e00120.


Bunglawala, Fazila, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Mirochnick, Mark, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2020) Prediction of dolutegravir pharmacokinetics and dose optimization in neonates via physiologically based pharmacokinetic (PBPK) modelling. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (3). pp. 640-647.


Scarsi, Kimberly K, Sayles, Harlan, Kapungu, Kelvin, Sifuna, Peter, Ippolito, Matthew M, Furl, Renae, Anderson, Matthew J, Ofimboudem, Joelle Dountio, Chongwe, Gershom, Hutter, Jack
et al (show 3 more authors) (2023) Preferences of Patients and Providers in High-Burden Malaria Settings for Long-Acting Malaria Chemoprevention. The American journal of tropical medicine and hygiene, 109 (4). pp. 752-760.


Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Rajoli, Rajith Kr ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 12 more authors) (2020) Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics. Clinical pharmacology and therapeutics, 108 (4). pp. 775-790.


Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan, Sharp, Joanne, Liptrott, Neill ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 11 more authors) (2020) Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics. Clinical Pharmacology and Therapeutics.


Neary, Megan ORCID: 0000-0002-4960-2139, Arshad, Usman ORCID: 0000-0003-1586-1885, Tatham, Lee ORCID: 0000-0001-9448-8876, Pertinez, Henry, Box, Helen, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Valentijn, Anthony, Sharp, Joanne, Rannard, Steve ORCID: 0000-0002-6946-1097, Biagini, Giancarlo ORCID: 0000-0001-6356-6595
et al (show 2 more authors) (2021) Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research. [Preprint]


Neary, Megan ORCID: 0000-0002-4960-2139, Arshad, Usman ORCID: 0000-0003-1586-1885, Tatham, Lee ORCID: 0000-0001-9448-8876, Pertinez, Henry, Box, Helen, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Valentijn, Anthony, Sharp, Joanne, Rannard, Steve P ORCID: 0000-0002-6946-1097, Biagini, Giancarlo A
et al (show 2 more authors) (2023) Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1228. 123823-.


Quinn, Tom M, Gaughan, Erin E, Bruce, Annya, Antonelli, Jean, O'Connor, Richard, Li, Feng, McNamara, Sarah, Koch, Oliver, MacKintosh, Claire, Dockrell, David
et al (show 39 more authors) (2022) Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics. EBIOMEDICINE, 76. 103856-.


Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony, Woods, Joana, Johnstone, Hilary, Akpomiemie, Godspower, Ellis, Leah, Owen, Andrew ORCID: 0000-0002-9819-7651, Casas, Carmen Perez
et al (show 1 more authors) (2022) Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (10). pp. 2706-2712.


Elbaz, Nancy M, Tatham, Lee M ORCID: 0000-0001-9448-8876, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve ORCID: 0000-0002-6946-1097 and McDonald, Tom O ORCID: 0000-0002-9273-9173
(2021) Redispersible nanosuspensions as a plausible oral delivery system for curcumin. Food Hydrocolloids, 121. p. 107005.


BUZIBYE, ALLAN, Wools-Kaloustian, Kara, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Twinomuhwezi, Ellon, Yiannoutsos, Constantin, Owen, Andrew ORCID: 0000-0002-9819-7651, Neary, Megan ORCID: 0000-0002-4960-2139, Matovu, Joshua, Banturaki, Grace, Castelnuovo, Barbara
et al (show 4 more authors) (2023) Relating CYP2B6 Genotype and EFV Resistance Among Women Living With HIV With High Viremia in Uganda: A Nested Cross-Sectional Study. AIDS Research and Therapy, 20 (1). 20-.


Buzibye, Allan, Wools-Kaloustian, Kara, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Twinomuhwezi, Ellon, Yiannoutsos, Constantin, Owen, Andrew, Neary, Megan ORCID: 0000-0002-4960-2139, Matovu, Joshua, Banturaki, Grace, Castelnuovo, Barbara
et al (show 4 more authors) (2023) Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional study. AIDS research and therapy, 20 (1). p. 20.


Jeffreys, Laura N, Pennington, Shaun H, Duggan, Jack, Caygill, Claire H, Lopeman, Rose C, Breen, Alastair F, Jinks, Jessica B, Ardrey, Alison, Donnellan, Samantha, Patterson, Edward I
et al (show 7 more authors) (2022) Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 59 (3). 106542-.


Nixon, Gemma L, McEntee, Laura, Johnson, Adam ORCID: 0000-0002-6684-3321, Farrington, Nikki, Whalley, Sarah, Livermore, Joanne, Natal, Cristien, Washbourn, Gina, Bibby, Jaclyn, Berry, Neil ORCID: 0000-0003-1928-0738
et al (show 6 more authors) (2018) Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease. Antimicrobial Agents and Chemotherapy, 62 (4). e01909-e01917.


Pepperrell, Toby, Pilkington, Victoria, Owen, Andrew ORCID: 0000-0002-9819-7651, Wang, Junzheng and Hill, Andrew M
(2020) Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19. JOURNAL OF VIRUS ERADICATION, 6 (2). pp. 52-60.


Chandiwana, Nomathemba, Kruger, Chelsea, Johnstone, Hilary, Chughlay, Mohamed Farouk, Ju, Chung, Kim, Byungsu, Dineka, Yengiwe, Arbe-Barnes, Sarah, Miller, Robert, Owen, Andrew ORCID: 0000-0002-9819-7651
et al (show 6 more authors) (2022) Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial. EBIOMEDICINE, 86. 104322-.


Hobson, James J ORCID: 0000-0003-2551-1774, Rannard, Steve P ORCID: 0000-0002-6946-1097, Owen, Andrew ORCID: 0000-0002-9819-7651 and Liptrott, Neill J ORCID: 0000-0002-5980-8966
(2020) Safety assessment of a new nanoemulsion-based drug-delivery system reveals unexpected, drug-free, anticoagulant activity. Nanomedicine, 15 (14). pp. 1361-1374.


Penman, Sophie L ORCID: 0000-0001-5326-1675, Kiy, Robyn T ORCID: 0000-0001-7960-7283, Jensen, Rebecca L ORCID: 0000-0003-1134-2869, Beoku‐Betts, Christopher, Alfirevic, Ana ORCID: 0000-0002-2801-9817, Back, David, Khoo, Saye H, Owen, Andrew ORCID: 0000-0002-9819-7651, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Park, B Kevin ORCID: 0000-0001-8384-824X
et al (show 3 more authors) (2020) Safety perspectives on presently considered drugs for the treatment of COVID‐19. British Journal of Pharmacology, 177 (19). pp. 4353-4374.


Hobson, James ORCID: 0000-0003-2551-1774, Savage, Alison, Dwyer, Andrew, Unsworth, Catherine, Arshad, Usman, Pertinez, Henry, box, helen, Tatham, Lee, Rajoli, Rajith ORCID: 0000-0002-6015-5712, Neary, Megan ORCID: 0000-0002-4960-2139
et al (show 8 more authors) (2021) Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection. Unknown.


Hobson, James Joseph ORCID: 0000-0003-2551-1774, Savage, Alison Clare ORCID: 0000-0002-5312-9946, Dwyer, Andrew, Unsworth, Catherine, Massam, Jonathan, Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee M ORCID: 0000-0001-9448-8876, Rajoli, Rajith ORCID: 0000-0002-6015-5712
et al (show 9 more authors) (2021) Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection. Nanoscale, 13 (13). pp. 6410-6416.


Hobson, James ORCID: 0000-0003-2551-1774, Savage, Alison, Dwyer, Andrew, Unsworth, Catherine, Arshad, Usman, Pertinez, Henry, box, helen, Tatham, Lee, Rajoli, Rajith KR, Neary, Megan
et al (show 8 more authors) (2021) Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection.


Hobson, James ORCID: 0000-0003-2551-1774, Al-Khouja, Amer, Curley, Paul ORCID: 0000-0003-4596-2708, Meyers, David, Flexner, Charles, Siccardi, Marco ORCID: 0000-0002-3539-7867, Owen, Andrew ORCID: 0000-0002-9819-7651, Freel Meyers, Caren and Rannard, SP ORCID: 0000-0002-6946-1097
(2019) Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies. Nature Communications, 10.


Clark, Jordan ORCID: 0000-0003-1790-7883, Penrice-Randal, Rebekah ORCID: 0000-0002-0653-2097, Sharma, Parul, Kipar, Anja, Dong, Xiaofeng, Pennington, Shaun, Marriott, Amy, Colombo, Stefano, Davidson, Andrew, Williamson, Maia Kavanagh
et al (show 16 more authors) (2020) Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19. bioRxiv.


Hiscox, Julian A ORCID: 0000-0002-6582-0275, Khoo, Saye H ORCID: 0000-0002-2769-0967, Stewart, James P ORCID: 0000-0002-8928-2037 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2021) Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance? JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (9). pp. 2230-2233.


Moss, Darren M, Domanico, Paul, Watkins, Melynda, Park, Seonghee, Randolph, Ryan, Wring, Steve, Rajoli, Rajith Kumar Reddy ORCID: 0000-0002-6015-5712, Hobson, James ORCID: 0000-0003-2551-1774, Rannard, Steve ORCID: 0000-0002-6946-1097, Siccardi, Marco ORCID: 0000-0002-3539-7867
et al (show 1 more authors) (2017) Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (7). e00105-e00117.


Salzer, Ralf, Clark, Jordan J, Vaysburd, Marina, Chang, Veronica T, Albecka, Anna, Kiss, Leo, Sharma, Parul, Llamazares, Andres Gonzalez, Kipar, Anja ORCID: 0000-0001-7289-3459, Hiscox, Julian A ORCID: 0000-0002-6582-0275
et al (show 5 more authors) (2021) Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice. FEBS LETTERS, 595 (18). pp. 2323-2340.


Rosslein, Matthias, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Owen, Andrew ORCID: 0000-0002-9819-7651, Boisseau, Patrick, Wick, Peter and Herrmann, Inge K
(2017) Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines. NANOTOXICOLOGY, 11 (2). pp. 147-149.


Giardiello, Marco ORCID: 0000-0003-0560-4711, Hatton, Fiona L, Slater, Rebecca A, Chambon, Pierre, North, Jocelyn, Peacock, Anita K, He, Tao, McDonald, Tom O ORCID: 0000-0002-9273-9173, Owen, Andrew ORCID: 0000-0002-9819-7651 and Rannard, Steve P ORCID: 0000-0002-6946-1097
(2016) Stable, polymer-directed and SPION-nucleated magnetic amphiphilic block copolymer nanoprecipitates with readily reversible assembly in magnetic fields. Nanoscale, 8 (13). pp. 7224-7231.


De Neck, Simon, Penrice-Randal, Rebekah ORCID: 0000-0002-0653-2097, Clark, Jordan J, Sharma, Parul, Bentley, Eleanor G, Kirby, Adam, Mega, Daniele F, Han, Ximeng, Owen, Andrew ORCID: 0000-0002-9819-7651, Hiscox, Julian A ORCID: 0000-0002-6582-0275
et al (show 2 more authors) (2023) The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings in Mouse Models of SARS-CoV-2, Influenza A and Gammaherpesvirus Infections. Viruses, 15 (8). p. 1637.


Owen, Andrew ORCID: 0000-0002-9819-7651 and Rannard, Steve ORCID: 0000-0002-6946-1097
(2016) Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy. ADVANCED DRUG DELIVERY REVIEWS, 103. pp. 144-156.


Pushpakom, Sudeep P ORCID: 0000-0002-6682-4235, Adaikalakoteswari, Antonysunil, Owen, Andrew ORCID: 0000-0002-9819-7651, Back, David J, Tripathi, Gyanendra, Kumar, Sudhesh, McTernan, Philip and Pirmohamed, Munir ORCID: 0000-0002-7534-7266
(2018) Telmisartan reverses antiretroviral-induced adipocyte toxicity and insulin resistance in vitro. Diabetes & vascular disease research, 15 (3). pp. 233-242.


Boffito, Marta, Back, David J, Flexner, Charles, Sjo, Peter, Blaschke, Terrence F, Horby, Peter W, Cattaneo, Dario, Acosta, Edward P, Anderson, Peter and Owen, Andrew ORCID: 0000-0002-9819-7651
(2021) Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID-19 Therapeutic Development. CLINICAL PHARMACOLOGY & THERAPEUTICS, 110 (1). pp. 64-68.


Tatham, L ORCID: 0000-0001-9448-8876, Dwyer, AB, Savage, Alison C ORCID: 0000-0002-5312-9946, Siccardi, M ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) Towards a Long-Acting Injectable (LAI) Formulation For Maraviroc. In: CROI, 2018-3-4 - 2018-3-7, Boston MA.


Tatham, Lee M ORCID: 0000-0001-9448-8876, Savage, Alison C ORCID: 0000-0002-5312-9946, Dwyer, Andrew, Siccardi, Marco ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Clark, Andrew, Rannard, Steven P ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2019) Towards a Maraviroc long-acting injectable nanoformulation. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 138. pp. 92-98.


Siccardi, Marco ORCID: 0000-0002-3539-7867, Martin, Phillip, Smith, Darren ORCID: 0000-0003-4925-467X, Curley, Paul ORCID: 0000-0003-4596-2708, McDonald, Tom, Giardiello, Marco ORCID: 0000-0003-0560-4711, Liptrott, Neill ORCID: 0000-0002-5980-8966, Rannard, Steve ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2016) Towards a rational design of solid drug nanoparticles with optimised pharmacological properties. Journal of interdisciplinary nanomedicine, 1 (3). pp. 110-123.


Niezabitowska, Edyta, Gray, Dominic MM, Gallardo-Toledo, Eduardo, Owen, Andrew ORCID: 0000-0002-9819-7651, Rannard, Steve PP ORCID: 0000-0002-6946-1097 and McDonald, Tom OO ORCID: 0000-0002-9273-9173
(2023) Understanding the Degradation of Core-Shell Nanogels Using Asymmetrical Flow Field Flow Fractionation. JOURNAL OF FUNCTIONAL BIOMATERIALS, 14 (7). 346-.


Sacramento, Carolina Q, Fintelman-Rodrigues, Natalia, Dias, Suelen SG, Temerozo, Jairo R, Da Silva, Aline de Paula D, da Silva, Carine S, Blanco, Camilla, Ferreira, Andre C, Mattos, Mayara, Soares, Vinicius C
et al (show 13 more authors) (2022) Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells. VIRUSES-BASEL, 14 (2). 374-.


Chang, Yong S, Li, Si-Yang, Pertinez, Henry, Betoudji, Fabrice, Lee, Jin, Rannard, Steven P ORCID: 0000-0002-6946-1097, Owen, Andrew ORCID: 0000-0002-9819-7651, Nuermberger, Eric L and Ammerman, Nicole C
(2023) Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 67 (7). e0048123-.


Atoyebi, Shakir Adeyinka ORCID: 0000-0002-1393-3753, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Adejuyigbe, Ebunoluwa, Owen, Andrew ORCID: 0000-0002-9819-7651, Bolaji, Oluseye, Siccardi, Marco ORCID: 0000-0002-3539-7867 and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2019) Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide <i>versus</i> efavirenz as case studies. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 140. 105068-.


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Nwogu, Jacinta, Eniayewu, Oluwasegun, Atoyebi, Shakir ORCID: 0000-0002-1393-3753, Amara, Alieu, Kpamor, John, Bolaji, Oluseye, Adejuyigbe, Ebunoluwa, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye
(2021) Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry. Wellcome Open Research, 6. p. 246.


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Nwogu, Jacinta ORCID: 0000-0002-0640-7165, Eniayewu, Oluwasegun, Atoyebi, Shakir ORCID: 0000-0002-1393-3753, Amara, Alieu ORCID: 0000-0002-1137-2948, Kpamor, John, Bolaji, Oluseye ORCID: 0000-0002-8295-7150, Adejuyigbe, Ebunoluwa, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2021) Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry. Wellcome open research, 6. 246-.


Siccardi, Marco ORCID: 0000-0002-3539-7867, Dickinson, Laura ORCID: 0000-0001-5557-9396 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2016) Validation of Computational Approaches for Antiretroviral Dose Optimization (vol 60, pg 3838, 2016). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (1). e02367-e02316.


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Anweh, Damien, Okafor, Ogechi, Dickinson, Laura ORCID: 0000-0001-5557-9396, Richman, Douglas ORCID: 0000-0003-0962-9254, Owen, Andrew ORCID: 0000-0002-9819-7651 and Adejuyigbe, Ebunoluwa ORCID: 0000-0002-8671-4965
(2019) Viral and antiretroviral dynamics in HIV mother-to-child transmission fluids (VADICT) – Protocol and data analysis plan for a cohort study. Wellcome Open Research, 4. p. 34.


Moss, Darren Michael, Curley, Paul ORCID: 0000-0003-4596-2708, Kinvig, Hannah ORCID: 0000-0002-0061-1683, Hoskins, Clare and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 12 (3). pp. 223-236.


Watson, Victoria
The clinical pharmacology of Human Immunodeficiency Virus (HIV) therapy failure. Doctor of Philosophy thesis, University of Liverpool.


Siccardi, Marco ORCID: 0000-0002-3539-7867, Rannard, Steve ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) The emerging role of physiologically based pharmacokinetic modelling in solid drug nanoparticle translation. Advanced Drug Delivery Reviews, 131. pp. 116-121.


Abdullahi, Sa'ad T, Soyinka, Julius O, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Bolarinwa, Rahman A, Olarewaju, Olusola J, Bakare-Odunola, Moji T, Winterberg, Markus, Tarning, Joel, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2020) <i>CYP2B6</i>*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers. JOURNAL OF CLINICAL PHARMACOLOGY, 60 (3). pp. 351-360.


Sacramento, Carolina Q, Fintelman-Rodrigues, Natalia, Temerozo, Jairo R, Dias Da Silva, Aline de Paula, Gomes Dias, Suelen da Silva, da Silva, Carine dos Santos, Ferreira, Andre C, Mattos, Mayara, Pao, Camila RR, de Freitas, Caroline S
et al (show 30 more authors) (2021) <i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (7). pp. 1874-1885.


Pushpakom, Sudeep P ORCID: 0000-0002-6682-4235, Owen, Andrew ORCID: 0000-0002-9819-7651, Back, David J and Pirmohamed, Munir ORCID: 0000-0002-7534-7266
(2013) <i>RXR</i> gene variants are associated with HIV lipodystrophy. PHARMACOGENETICS AND GENOMICS, 23 (8). pp. 438-441.


Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Owen, Andrew ORCID: 0000-0002-9819-7651, Walker, A Sarah, Gibb, DianaM
et al (show 3 more authors) (2016) The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 82 (1). pp. 185-198.


Silva, Adny Henrique, Lima, Enio Jr, Mansilla, Marcelo Vasquez, Zysler, Roberto Daniel, Mojica Pisciotti, Mary Luz, Locatelli, Claudriana, Rajoli, Rajith Kumar Reddy ORCID: 0000-0002-6015-5712, Owen, Andrew ORCID: 0000-0002-9819-7651, Creczynski-Pasa, Tania Beatriz and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2017) A physiologically based pharmacokinetic model to predict the superparamagnetic iron oxide nanoparticles (SPIONs) accumulation in vivo. EUROPEAN JOURNAL OF NANOMEDICINE, 9 (2). pp. 79-90.


Huo, Jiandong, Mikolajek, Halina, Le Bas, Audrey, Clark, Jordan J, Sharma, Parul, Kipar, Anja ORCID: 0000-0001-7289-3459, Dormon, Joshua, Norman, Chelsea, Weckener, Miriam, Clare, Daniel K
et al (show 23 more authors) (2021) A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. NATURE COMMUNICATIONS, 12 (1). 5469-.


Fowotade, Adeola, Bamidele, Folasade, Egbetola, Boluwatife, Fagbamigbe, Adeniyi F, Adeagbo, Babatunde A, Adefuye, Bolanle O, Olagunoye, Ajibola, Ojo, Temitope O, Adebiyi, Akindele O, Olagunju, Omobolanle I
et al (show 8 more authors) (2022) A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19. FRONTIERS IN MEDICINE, 9. 956123-.


Owen, Andrew
(2002) The role of P-glycoprotein in treatment-resistant epilepsy. PhD thesis, University of Liverpool.


Zhang, Yuan
The role of drug disposition genes for variability in the pharmacokinetics of antiretroviral drugs. Doctor of Philosophy thesis, University of Liverpool.

This list was generated on Mon Feb 5 00:53:38 2024 GMT.